SCHEMBL18744137

SCHEMBL18744137

CP1(=O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@@H](O)[C@@H]2O1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ THRB P10828 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ MDM2 Q00987 1/20 0.50
▸ NCOA1 Q15788 1/20 0.50
▸ NCOA3 Q9Y6Q9 1/20 0.50
▸ RAPGEF3 O95398 3/20 0.48
▸ STING1 Q86WV6 6/20 0.45
▸ PDE3B Q13370 1/20 0.45
▸ PDE3A Q14432 1/20 0.45
▸ GMNN O75496 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RAPGEF4 Q8WZA2 1/20 0.43
▸ RXFP1 Q9HBX9 2/20 0.43
▸ NT5E P21589 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13176571 1.00 LMNA (0.50) LMNATHRBMTORMDM2NCOA1
SCHEMBL1331888 0.88 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL19954155 0.88 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL16561105 0.88 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL17826621 0.87 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL18744120 0.85 LMNA (0.39) LMNATHRBMTORMDM2NCOA1
SCHEMBL18720751 0.84 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL18742090 0.82 LMNA (0.43) LMNATHRBMTORMDM2NCOA1
SCHEMBL30847445 0.81 STING1 (0.54) LMNARAPGEF3STING1PDE3BPDE3A
SCHEMBL15259214 0.81 LMNA (0.52) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624249-B2 Nucleoside kinase bypass compositions and methods MERCK SHARP & DOHME CORP. (US) 2017-04-18 — — US disclosed
Send feedback